Literature DB >> 10704821

Activation of stat3 and stat1 DNA binding and transcriptional activity in human brain tumour cell lines by gp130 cytokines.

L K Schaefer1, D G Menter, T S Schaefer.   

Abstract

In this study we examine the activation of the latent Stat family of transcription factors by the gp130 family of cytokines in cell lines derived from human brain tumours. Of the cytokines tested, oncostatin M resulted in the most dramatic induction of Stat1 and Stat3 in all cell lines analysed, as assessed by the formation of protein/DNA complexes. Interleukin-6, leukemia inhibitory factor, and ciliary neurotrophic factor also induced Stat complexes more selectively and to a lesser magnitude than oncostatin M. The kinetics of Stat1 and Stat3 activation was rapid and transient; the nuclear accumulation of DNA binding-proficient Stat protein was detected in the nucleus within minutes of cytokine induction. The transcriptional potential of the oncostatin M-activated Stat molecules was demonstrated in two glioma cell lines (U87-MG, SNB-19) by transient transfection experiments using a Stat-responsive reporter plasmid. Oncostatin M-dependent transcription from this reporter plasmid was reduced to uninduced levels by the inclusion of a dominant-negative Stat3 molecule, demonstrating that Stat molecules were responsible for the induction. These studies demonstrate that oncostatin M is the most potent activator of Stat molecules in a variety of brain tumour-derived cell lines, an observation that could have implications affecting the balance between proliferation/apoptosis of these cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10704821     DOI: 10.1016/s0898-6568(99)00077-7

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  13 in total

1.  STAT3 tyrosine phosphorylation influences survival in glioblastoma.

Authors:  Peter Birner; Kalina Toumangelova-Uzeir; Sevdalin Natchev; Marin Guentchev
Journal:  J Neurooncol       Date:  2010-05-09       Impact factor: 4.130

2.  STAT3-iNOS Signaling Mediates EGFRvIII-Induced Glial Proliferation and Transformation.

Authors:  Sidharth V Puram; Caleb M Yeung; Arezu Jahani-Asl; Chieyu Lin; Nuria de la Iglesia; Genevieve Konopka; Laurie Jackson-Grusby; Azad Bonni
Journal:  J Neurosci       Date:  2012-06-06       Impact factor: 6.167

3.  Constitutively activated STAT3 frequently coexpresses with epidermal growth factor receptor in high-grade gliomas and targeting STAT3 sensitizes them to Iressa and alkylators.

Authors:  Hui-Wen Lo; Xinyu Cao; Hu Zhu; Francis Ali-Osman
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

4.  Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells.

Authors:  Jeongwu Lee; Myung Jin Son; Kevin Woolard; Nicholas M Donin; Aiguo Li; Chui H Cheng; Svetlana Kotliarova; Yuri Kotliarov; Jennifer Walling; Susie Ahn; Misuk Kim; Mariam Totonchy; Thomas Cusack; Chibawanye Ene; Hilary Ma; Qin Su; Jean Claude Zenklusen; Wei Zhang; Dragan Maric; Howard A Fine
Journal:  Cancer Cell       Date:  2008-01       Impact factor: 31.743

5.  Epidermal growth factor receptor dependence of radiation-induced transcription factor activation in human breast carcinoma cells.

Authors:  George P Amorino; Virginia M Hamilton; Kristoffer Valerie; Paul Dent; Guido Lammering; Rupert K Schmidt-Ullrich
Journal:  Mol Biol Cell       Date:  2002-07       Impact factor: 4.138

6.  Blockage of the STAT3 signaling pathway with a decoy oligonucleotide suppresses growth of human malignant glioma cells.

Authors:  Jinhai Gu; Gang Li; Tao Sun; Yuhang Su; Xulong Zhang; Jie Shen; Zhigang Tian; Jian Zhang
Journal:  J Neurooncol       Date:  2008-04-16       Impact factor: 4.130

Review 7.  Signal transducer and activator of transcription-3: a molecular hub for signaling pathways in gliomas.

Authors:  Emily C Brantley; Etty N Benveniste
Journal:  Mol Cancer Res       Date:  2008-05       Impact factor: 5.852

8.  A dual role for oncostatin M signaling in the differentiation and death of mammary epithelial cells in vivo.

Authors:  Paul G Tiffen; Nader Omidvar; Nuria Marquez-Almuina; Dawn Croston; Christine J Watson; Richard W E Clarkson
Journal:  Mol Endocrinol       Date:  2008-10-16

Review 9.  STAT3 as a target for inducing apoptosis in solid and hematological tumors.

Authors:  Khandaker Al Zaid Siddiquee; James Turkson
Journal:  Cell Res       Date:  2008-02       Impact factor: 25.617

10.  Generation and characterization of a constitutively active Stat3 protein.

Authors:  Juan A Barboza; Shuguang Wang; Timothy S Schaefer
Journal:  Mol Biol Rep       Date:  2004-03       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.